Immunome, Inc. (IMNM)
18.71
+0.80
(+4.50%)
USD |
NASDAQ |
Nov 06, 16:00
19.49
+0.78
(+4.17%)
After-Hours: 20:00
Immunome Total Long Term Debt (Quarterly) : 4.588M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.588M |
| March 31, 2026 | 3.694M |
| December 31, 2025 | 3.855M |
| September 30, 2025 | 4.013M |
| June 30, 2025 | 4.142M |
| March 31, 2025 | 4.77M |
| December 31, 2024 | 4.769M |
| September 30, 2024 | 2.464M |
| June 30, 2024 | 2.477M |
| March 31, 2024 | 1.206M |
| December 31, 2023 | 1.34M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.093M |
| June 30, 2022 | 0.124M |
| March 31, 2022 | 0.147M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.016M |
| June 30, 2021 | 0.044M |
| March 31, 2021 | 0.578M |
| December 31, 2020 | 0.613M |
| September 30, 2020 | 49.03M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Revolution Medicines, Inc. | 1.202B |
| Erasca, Inc. | 39.27M |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |